UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5705-5712

2008

Volltextzugriff (PDF)

Functions and Regulation of the PTEN Gene in Colorectal Cancer

Frontiers in oncology, 2014-01, Vol.3, p.326-326

2014

Volltextzugriff (PDF)

Functional and clinical significance of ROR1 in lung adenocarcinoma

BMC cancer, 2020-11, Vol.20 (1), p.1085-1085, Article 1085

2020

Volltextzugriff (PDF)

A qPCR technology for direct quantification of methylation in untreated DNA

Nature communications, 2023-08, Vol.14 (1), p.5153-5153, Article 5153

2023

Volltextzugriff (PDF)

KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

Clinical cancer research, 2012-03, Vol.18 (6), p.1769-1776

2012

Volltextzugriff (PDF)

Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer

PloS one, 2009-10, Vol.4 (10), p.e7287-e7287

2009

Volltextzugriff (PDF)

One-instrument, objective microsatellite instability analysis using high-resolution melt

PloS one, 2024-04, Vol.19 (4), p.e0302274-e0302274

2024

Volltextzugriff (PDF)

Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers

Cancers, 2022-08, Vol.14 (17), p.4103

2022

Volltextzugriff (PDF)

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer

Journal of clinical medicine, 2022-12, Vol.11 (24), p.7523

2022

Volltextzugriff (PDF)

Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3

PloS one, 2017-10, Vol.12 (10), p.e0187289-e0187289

2017

Volltextzugriff (PDF)

Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer

Clinical cancer research, 2011-07, Vol.17 (14), p.4901-4914

2011

Volltextzugriff (PDF)

Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen® FFPE BRAF qPCR assay

PloS one, 2023-02, Vol.18 (2), p.e0281558-e0281558

2023

Volltextzugriff (PDF)

A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies

PloS one, 2021-06, Vol.16 (6), p.e0253687-e0253687

2021

Volltextzugriff (PDF)

Correction to: Functional and clinical significance of ROR1 in lung adenocarcinoma

BMC cancer, 2020-12, Vol.20 (1), p.1-1196, Article 1196

2020

Volltextzugriff (PDF)

NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels

Glycobiology (Oxford), 2015-08, Vol.25 (8), p.855-868

2015

Volltextzugriff (PDF)

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

The oncologist (Dayton, Ohio), 2017-07, Vol.22 (7), p.782-e70

2017

Volltextzugriff (PDF)

Antiandrogens as Therapies for COVID-19: A Systematic Review

Cancers, 2024-01, Vol.16 (2), p.298

2024

Volltextzugriff (PDF)

Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR

PloS one, 2018-01, Vol.13 (1), p.e0191593-e0191593

2018

Volltextzugriff (PDF)

The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation

Frontiers in oncology, 2020-01, Vol.9, p.1569-1569

2020

Volltextzugriff (PDF)

APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylation

Virchows Archiv : an international journal of pathology, 2014-05, Vol.464 (5), p.553-564

2014

Volltextzugriff (PDF)

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer

Oncogene, 2004-09, Vol.23 (44), p.7436-7440

2004

Volltextzugriff (PDF)

CT evaluation of lung infiltrates in the two months preceding the Coronavirus disease 19 pandemic in Canton Ticino (Switzerland): were there suspicious cases before the official first case?

Radiologia medica, 2022-04, Vol.127 (4), p.360-368

2022

Volltextzugriff (PDF)

Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer

International journal of cancer, 2010-12, Vol.127 (11), p.2569-2575

2010

Volltextzugriff (PDF)

Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy

Journal of clinical medicine, 2022-03, Vol.11 (6), p.1627

2022

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Japanisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

Functions and Regulation of the PTEN Gene in Colorectal Cancer

Functional and clinical significance of ROR1 in lung adenocarcinoma

A qPCR technology for direct quantification of methylation in untreated DNA

KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer

One-instrument, objective microsatellite instability analysis using high-resolution melt

Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer

Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3

Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer

Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen® FFPE BRAF qPCR assay

A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies

Correction to: Functional and clinical significance of ROR1 in lung adenocarcinoma

NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

Antiandrogens as Therapies for COVID-19: A Systematic Review

A Pilot, Prospective, Observational Study to Investigate the Value of NGS in Liquid Biopsies to Predict Tumor Response After Neoadjuvant Chemo-Radiotherapy in Patients With Locally Advanced Rectal Cancer: The LiBReCa Study

Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR

The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation

APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylation

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer

CT evaluation of lung infiltrates in the two months preceding the Coronavirus disease 19 pandemic in Canton Ticino (Switzerland): were there suspicious cases before the official first case?

Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer

Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy

Aktive Filter

Suchergebnisse filtern